Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 1/2016

01-01-2016 | Original Article

Unplanned oncology admissions within 14 days of non-surgical discharge: a retrospective study

Authors: Samantha Gibson, Ruth McConigley

Published in: Supportive Care in Cancer | Issue 1/2016

Login to get access

Abstract

Aim

The aim of this study was to identify the incidence, causes, risk factors and interventions for cancer patients requiring unplanned admissions within 14 days of discharge at a large metropolitan private hospital without a co-located emergency department.

Methods

Retrospective data were collected on cancer patients who had an unplanned admission within 14 days of discharge during the period December 1, 2011 and May 31, 2012. Data were collected from the inpatient bed administration database and medical record review. Variables collected included demographics, cancer diagnosis, reasons for admission, interventions, and length of stay.

Results

A total of 133 oncology patients required 206 unplanned admissions (UPAs). The most common cancer diagnoses associated with unplanned readmission were upper gastrointestinal (25.4 %), colorectal (19.6 %), gynaecological (18.8 %) and breast (13.8 %) cancers. The symptoms most commonly associated with unplanned re-admission were pain (16 %); infection not associated with neutropaenia (15.5 %); fever and febrile neutropaenia (14.6 %); nausea, vomiting and dehydration (13.6 %); dyspnoea (8.3 %) and altered neurological status (7.8 %). The median length of stay (LOS) was 6 days. Length of stay during UPA was decreased for patients with a partner and for those who had a palliative care consult. The need for psychological supports was related to a longer LOS during UPA.

Conclusion

Cancer patients are at a significant risk of requiring unscheduled care and admission. Strategies and services to limit the burden on patients and the health care system should be reviewed to minimise the incidence of unplanned admission.
Literature
1.
McKenzie H, Hayes L, White K, Cox K, Fethney J, Boughton M, Dunn J (2010) Chemotherapy outpatients’ unplanned presentations to hospital: a retrospective study. Support Care Cancer 19:963–969CrossRefPubMed
2.
Hassett MJ, O’Malley AJ, Pakes JR, Newhouse JP, Earle CC (2006) Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer. J Natl Cancer Inst 98(16):1108–1117CrossRefPubMed
3.
Livingston PM, Craike M, Considine J (2011) Unplanned presentation to emergency departments due to chemotherapy induced complications: opportunities for improving service delivery. Aust Emerg Nurs J 14:62–68CrossRef
4.
Mitchell T (2007) The social and emotional toll of chemotherapy—patients’ perspectives. Eur J Cancer Care 16:39–47CrossRef
5.
6.
Henretta MS, Scalici JM, Engelhard CL, Duska LR (2011) The revolving door: hospital readmissions of gynaecologic oncology patients. Gynecol Oncol 122:479–483CrossRefPubMed
7.
8.
Cohen L, de Moor CA, Eisenberg P, Ming EE, Hu H (2007) Chemotherapy-induced nausea and vomiting—incidence and impact on patient quality of life at community oncology settings. Support Care Cancer 15:497–503CrossRefPubMed
9.
Fromme EK, Eilers KM, Mori M, Hsieh Y-C, Beer TM (2004) How accurate is clinical reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the quality-of-life questionnaire C30. J Clin Oncol 22(17):3485–3490CrossRefPubMed
10.
Considine J, Livingston P, Bucknall T, Botti M (2009) A review of the role of emergency nurses in management of chemotherapy-related complications. J Clin Nurs 18:2649–2655CrossRefPubMed
11.
Martin CG, Kennedy KF, Elting LS, Manzullo EM, Escalante CP, Rubenstein EB (1996) Incidence of emergency visits among oncology patients receiving outpatient chemotherapy: implications for care in a capitated market. Cancer Control 3(5):435–441PubMed
12.
Tas F, Argon A, Disci R, Topuz E (2007) Pattern and outcome of admission to a medical oncology inpatient service. J Cancer Educ 22(2):80–85CrossRefPubMed
13.
Nirenberg A, Mulhearn L, Lin S, Larson E (2004) Emergency department waiting times for patients with febrile neutropaenia: a pilot study. Oncol Nurs Forum 31(4):711–715CrossRefPubMed
14.
Callen JL, Blundell L, Prgomet M (2008) Emergency department use in a rural Australian setting: are factors prompting attendance appropriate? Aust Health Rev 32(4):710–720CrossRefPubMed
15.
Diaz-Couselo FA, OÇonnor MJ, Nervo A, Tossen G, Guercovich A, Puparelli C, Zylberman M (2004) Nonscheduled consultation in oncologic patients. How many of these are true emergencies? An observational prospective study? Support Care Cancer 12:274–277CrossRefPubMed
16.
Craike MJ, Livingston PM, Considine M (2010) Emergency department presentations of patients from CALDB receiving chemotherapy in day oncology settings. Aust Emerg Nurs J 13:111–116CrossRef
17.
Bozdemir N, Eray A, Senol Y, Artac M, Samur M (2009) Demographics, clinical presentations and outcomes of cancer patients admitted to the emergency department. Turk J Med Sci 39(2):235–240
18.
Majem M, Galan M, Perez FJ, Munoz M, Chicote S, Soler G, Germa JR (2007) The oncology acute toxicity unit (OATU): an outpatient facility for improving the management of chemotherapy toxicity. Clin Transl Oncol 9:784–788CrossRefPubMed
19.
20.
Tsai S-C, Liu L-N, Tang S-T, Chen J-C, Chen M-L (2010) Cancer pain as the presenting problem in emergency departments: incidence and related factors. Support Care Cancer 18:57–65CrossRefPubMed
21.
Dennis K, Librach SL, Chow E (2011) Palliative care and oncology: integration leads to better care. Oncology (Williston Park) 25:1271–1275
22.
Brunetto AT, Ang JE, Olmos D, Tan D, Bariuso J, Arkenau H-T, Kaye S (2010) A study of the pattern of hospital admissions in a specialist phase I oncology trials unit: unplanned admissions as an early indicator of patient attrition. Eur J Cancer 46:2739–2745CrossRefPubMed
23.
Weaver C, Schiech L, Held-Warmkessel J, Kadziera P, Haney E, DiLullo G, Barsevick A (2006) Risk of unplanned hospital readmission of patients with cancer: results of a retrospective medical record review. Oncol Nurs Forum 33(3):E44–E52CrossRefPubMed
24.
deBoer A, Wijker W, de Haes H (1997) Predictors of health care utilization in the chronically ill: a review of the literature. Health Policy 42(2):101–115CrossRef
25.
Puts MTE, Monette J, Girre V, Wolfson C, Monette M, Batist G, Bergman H (2010) Does frailty predict hospitalization, emergency department visits and visits to the general practitioner in older newly-diagnosed cancer patients? Results of a prospective pilot study. Crit Rev Oncol Hematol 76:142–151CrossRefPubMed
26.
Yates M, Barrett A (2009) Oncological emergency admissions to the Norfolk and Norwich university hospital: an audit of current arrangements and patient satisfaction. Clin Oncol 21:226–233CrossRef
27.
Du XL, Osborne C, Goodwin JS (2002) Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer. J Clin Oncol 20(24):4636–4642PubMedCentralCrossRefPubMed
28.
Lai JK, Martin MA, Meyricke R, O’Neill T, Roberts S (2007) Factors associated with short-term hospital readmission rates for breast cancer patients in western Australia: an observational study. J Am Coll Surg 204(2):193–200CrossRefPubMed
29.
Molassiotis A, Brearly S, Saunders M, Craven O, Wardley A, Farrell C, Luker K (2008) Effectiveness of a home care nursing program in the symptom management of patients with colorectal and breast cancer receiving oral chemotherapy: a randomized control trial. J Clin Oncol 27(36):6191–6197CrossRef
30.
Graham D and McKerrow J (2006) Frequency of urgent/emergency symptoms assessed by triaging nurse for oncology patients seeking treatment at a comprehensive cancer centre. ONS Congress Abstract 2006
31.
Miranda V, Fede A, Nobuo M, Ayres V, Giglio A, Miranda M, Riechalmann MD (2011) Adverse drug reactions and drug interactions as causes of hospital admission in oncology. J Pain Symptom Manag 42(3):342–353CrossRef
32.
Courtney MD, Aldeen AZ, Gorman SM, Handler JA, Trifilio SM, Parada JP, Bennett CL (2007) Cancer- associated neutropenic fever: clinical outcome and economic costs of emergency department care. Oncologist 12:1019–1026CrossRefPubMed
33.
Lim JH, Kim H, Choi WG, Kim KH, Shin DW, Lee MH (2011) Outcomes in 102 patients that presented to the emergency department with chemotherapy-induced febrile neutropaenia. Turk J Hematol 28:193–197CrossRef
34.
Klatersky J, Paesmans M, Georgala A, Muanza F, Plehiers B, Dubreucq L, Barette M (2006) Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications. J Clin Oncol 24(25):4129–4134CrossRef
35.
Innes H, Marshall E (2007) Outpatient therapy for febrile neutropaenia. Curr Opin Oncol 19:294–298PubMed
36.
Demshar R, Vanek R, Mazanec P (2011) Oncologic emergencies new decade, new perspectives. AACN Adv Crit Care 22(4):337–348CrossRefPubMed
37.
Blinman PL, Grimison P, Barton MB, Crossing S, Walpole ET, Wong N, Koczwara B (2012) The shortage of medical oncologists: the Australian medical oncology workforce study. Med J Aust 196(1):58–61CrossRefPubMed
38.
Huws DW, Cashmore D, Newcombe RG, Roberts A, Vincent J, Elwyn G (2008) Impact of case management by advanced practice nurses in primary care on unplanned hospital admissions: a controlled intervention study. BMC Health Serv Res 8:115PubMedCentralCrossRefPubMed
Metadata
Title
Unplanned oncology admissions within 14 days of non-surgical discharge: a retrospective study
Authors
Samantha Gibson
Ruth McConigley
Publication date
01-01-2016
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 1/2016
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-015-2786-6

Other articles of this Issue 1/2016

Supportive Care in Cancer 1/2016 Go to the issue

Original Article

Identifying trajectory clusters in breast cancer survivors’ supportive care needs, psychosocial difficulties, and resources from the completion of primary treatment to 8 months later

Original Article

Phase II trial of epidermal growth factor ointment for patients with Erlotinib-related skin effects

Original Article

Hypofractionated palliative radiotherapy for bladder cancer

Original Article

The association between the strength of the working alliance and sharing concerns by advanced cancer patients: a pilot study

Original Article

Using a personalized measure (Patient Generated Index (PGI)) to identify what matters to people with cancer

Original Article

Developing a clinical pathway for the identification and management of anxiety and depression in adult cancer patients: an online Delphi consensus process
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits